Clinical performance of artificial intelligence-powered annotation of tumor cell PD-L1 expression for treatment of immune-checkpoint inhibitor (ICI) in advanced non-small cell lung cancer (NSCLC).

被引：2
|
作者：
Kim, Hyojin
Choi, Sangjoon
Kim, Seokhwi
Aum, Jaehong
Pereira, Sergio
Park, Seonwook
Ma, Minuk
Shin, Seunghwan
Paeng, Kyunghyun
Yoo, Donggeun
Jung, Wonkyung
Ock, Chan-Young
Lee, Se-Hoon
Chung, Jin-haeng
Choi, Yoon-La
Mok, Tony S. K.
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[3] Ajou Univ, Sch Med, Dept Pathol, Suwon, South Korea
[4] Lunit Inc, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Med, Seoul, South Korea
[7] Chinese Univ Hong Kong, State Key Lab Translat Oncol, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9026
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer
    Kim, Hyojin
    Kim, Seokhwi
    Choi, Sangjoon
    Park, Changhee
    Park, Seonwook
    Pereira, Sergio
    Ma, Minuk
    Yoo, Donggeun
    Paeng, Kyunghyun
    Jung, Wonkyung
    Park, Sehhoon
    Ock, Chan-Young
    Lee, Se-Hoon
    Choi, Yoon-La
    Chung, Jin-Haeng
    JCO PRECISION ONCOLOGY, 2024, 8
  • [2] Artificial intelligence-powered retrospective analysis of PD-L1 expression in nivolumab trials of advanced non-small cell lung cancer
    Baxi, Vipul
    Beck, Andrew
    Pandya, Dimple
    Lee, George
    Hedvat, Cyrus
    Khosla, Aditya
    Wang, Dayong
    Elliott, Hunter
    Pokkalla, Harsha
    Lahiri, Abhik
    Glass, Benjamin
    Kerner, Jennifer
    Wapinski, Ilan
    Chasalow, Scott
    Chang, Han
    Edwards, Robin
    Montalto, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [3] Artificial Intelligence-Powered Analyzer Reduces Inter-observer Variation in PD-L1 Tumor Proportion Score of Non-Small Cell Lung Cancer
    Kim, Seokhwi
    Choi, Sangjoon
    Cho, Soo Ick
    Kim, Hyojin
    Ma, Minuk
    Pereira, Sergio
    Park, Seonwook
    Aum, Brian
    Shin, Seunghwan
    Paeng, Kyunghyun
    Yoo, Donggeun
    Jung, Wonkyung
    Ock, Chan-Young
    Lee, Se-Hoon
    Chung, Jin-Haeng
    Choi, Yuna
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1247 - 1248
  • [4] Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)
    Robinson, I.
    Hochmair, M. J.
    Ay, L.
    Absenger, G.
    Jansen, C.
    Pacifico, C.
    Sladek, B.
    Knabl, A.
    Gasche, N.
    Valipour, A.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1400 - S1400
  • [5] Artificial Intelligence-Powered Analyzer Reduces Inter-observer Variation in PD-L1 Tumor Proportion Score of Non-Small Cell Lung Cancer
    Kim, Seokhwi
    Choi, Sangjoon
    Cho, Soo Ick
    Kim, Hyojin
    Ma, Minuk
    Pereira, Sergio
    Park, Seonwook
    Aum, Brian
    Shin, Seunghwan
    Paeng, Kyunghyun
    Yoo, Donggeun
    Jung, Wonkyung
    Ock, Chan-Young
    Lee, Se-Hoon
    Chung, Jin-Haeng
    Choi, Yuna
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1247 - 1248
  • [6] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [7] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
    Angelicola, Stefania
    Giunchi, Francesca
    Ruzzi, Francesca
    Frascino, Mariateresa
    Pitzalis, Mary
    Scalambra, Laura
    Semprini, Maria Sofia
    Pittino, Olga Maria
    Cappello, Chiara
    Siracusa, Irene
    Chillico, Ilaria Candida
    Di Noia, Martina
    Turato, Cristian
    De Siervi, Silvia
    Lescai, Francesco
    Ciavattini, Teresa
    Lopatriello, Giulia
    Bertoli, Luca
    De Jonge, Hugo
    Iamele, Luisa
    Altimari, Annalisa
    Gruppioni, Elisa
    Ardizzoni, Andrea
    Rossato, Marzia
    Gelsomino, Francesco
    Lollini, Pier-Luigi
    Palladini, Arianna
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [9] Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
    Li, Lijun
    Pu, Haihong
    Zhang, Xiaoxin
    Guo, Xiaotian
    Li, Guangrui
    Zhang, Minghui
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 209
  • [10] Assistance with an artificial intelligence-powered PD-L1 analyzer reduces interobserver variation in pathologic reading of tumor proportion score in non-small cell lung cancer
    Choi, S.
    Kim, S.
    Kim, H.
    Cho, S.
    Ma, M.
    Park, S.
    Pereira, S.
    Aum, B. J.
    Shin, S.
    Paeng, K.
    Yoo, D.
    Jung, W.
    Ock, C-Y
    Lee, S-H
    Choi, Y-L
    Chung, J-H
    Mok, T. S. K.
    ANNALS OF ONCOLOGY, 2021, 32 : S1228 - S1228
12345